Completed NA INTERVENTIONAL 2-arm NCT04324528

Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation (CYCOV)

Sponsor: Dr. Alexander Supady

Conditions COVID-19 Coronavirus Cytokine Storm Respiratory Failure SARS-CoV Infection

Interventions vv-ECMO + cytokine adsorption (Cytosorb adsorber) vv-ECMO only (no cytokine adsorption)

Updated 6 times since 2020 Last updated: Mar 11, 2021 Started: Mar 27, 2020 Primary completion: Jan 27, 2021 Completion: Jan 27, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on COVID-19 and Coronavirus, this trial is completed. The trial is conducted by Dr. Alexander Supady and has accumulated 6 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Apr 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr. Alexander Supady

Data source: University Hospital Freiburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Freiburg im Breisgau, Germany